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Mononuclear gold(III) complexes with L-histidine-containing 
dipeptides: tuning the structural and biological properties by 
variation of the N-terminal amino acid and counter anion† 
Beata Warżajtis,a Biljana Đ. Glišić,b Nada D. Savić,b Aleksandar Pavić,c Sandra Vojnovic,c  
Aleksandar Veselinović,d Jasmina Nikodinovic-Runic,*c Urszula Rychlewska*a and Miloš I. Djuran*b 
Gold(III) complexes with  different L-histidine-containing dipeptides, [Au(Gly-L-His-NA,NP,N3)Cl]Cl
.3H2O (1a), [Au(Gly-L-His-
NA,NP,N3)Cl]NO3
.1.25H2O (1b), [Au(L-Ala-L-His-NA,NP,N3)Cl][AuCl4]
.H2O (2a), [Au(L-Ala-L-His-NA,NP,N3)Cl]NO3
.2.5H2O (2b), 
[Au(L-Val-L-His-NA,NP,N3)Cl]Cl
.2H2O (3), [Au(L-Leu-L-His-NA,NP,N3)Cl]Cl (4a) and [Au(L-Leu-L-His-NA,NP,N3)Cl][AuCl4]
.H2O 
(4b) have been synthesized and structurally characterized by spectroscopic (1H NMR, IR and UV-vis) and single-crystal X-ray 
diffraction techniques. The antimicrobial efficiency of these gold(III) complexes, along with K[AuCl4] and the corresponding 
dipeptides, was evaluated against the broad panel of Gram-positive and Gram-negative bacteria and fungi, displaying their 
moderate inhibiting activity. Moreover, cytotoxic properties of the investigated complexes were assessed against the 
normal human lung fibroblast cell line (MRC5) and two human cancer, cervix (HeLa) and lung (A549) cell lines. None of the 
complexes exerted significant cytotoxic activity; nevertheless complexes that did show selectivity in terms of cancer vs. 
normal cell lines (2a/b and 4a/b) have been evaluated using zebrafish (Danio rerio) embryos for toxicity and antiangiogenic 
potential. Although the gold(III) complexes achieved antiangiogenic effect comparable to the known angiogenic inhibitors 
auranofin and sunitinib malate at 30-fold higher concentrations, they had no cardiovascular side effects, which commonly 
accompany auranofin and sunitinib malate treatment.  Finally, binding of the gold(III) complexes to the active sites of both 
human and bacterial (Escherichia coli) thioredoxin reductases (TrxRs) was demonstrated by molecular docking study, 
suggesting that the mechanism of biological action of these complexes can be associated with their interaction with the 
TrxR active site.  
Introduction 
 
Among the twenty proteinogenic amino acids, L-histidine (L-
His) plays a crucial role in biological systems due to its 
aromatic imidazole moiety, which is a common coordinating 
ligand in metalloproteins and a part of the catalytic site in 
several enzymes.1-3 The heterocyclic imidazole system in the L-
histidine provides two competitive nitrogen donor atoms, 
designated as N1 and N3. Thus, in some metalloproteins, 
metal ion is bound to the imidazole ring through N1 nitrogen 
only (Fe(II) in hemoglobin),4 while in the active site of the 
others, imidazole ring is coordinated through N3 (Zn(II) in 
superoxide dismutase).5 Besides that, a metal ion can have a 
mixed donor site sphere, as Cu(II) in superoxide dismutase 
((N3)2, N1term, N1bridge),
5 or in some metalloproteins the same 
metal ion displays different environments (Cu1(N3)2 and 
Cu3(N1)8 in ascorbate oxidase).
6 In majority of metal 
complexes with L-histidine-containing ligands, such as 
copper(II),7 platinum(II)8 and palladium(II)9-11 complexes with 
glycyl-L-histidine (Gly-L-His), the imidazole ring is coordinated 
to the corresponding metal ion through the N3 nitrogen. 
Complexes, in which histidine is coordinated through the N1 
nitrogen, are relatively rare.12-18  
Peptides containing L-histidine amino acid have been 
shown as good chelating ligands for Au(III) ion.9,19-22 Although 
reactions of the Au(III) ion with these peptides have been 
extensively investigated,19-22 only a few gold(III)–peptide 
complexes were synthesized and characterized by single-
crystal X-ray diffraction analysis.9,19,20 Crystallographic results 
for gold(III) complexes with L-histidine-containing peptides 
showed that these peptides are coordinated to the Au(III) ion 
through the N3 imidazole nitrogen, the deprotonated nitrogen 
of the amide bond(s) (NP) and to the nitrogen of the N-
terminal amino group (NA). From the previous studies,
9,19,20 it 
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was confirmed that the N3-anchored Au(III) ion was able to 
deprotonate amide nitrogen in L-histidine-containing peptides 
even at pH < 2.00. Moreover, it was shown that these peptides 
were more reactive with Au(III) than those containing no 
heteroatom in the side chain.23 Difference in the reactivity 
between these two types of peptides resulted from the fact 
that the N3-histidine anchoring the Au(III) ion was more 
effective at displacing the amide proton than Au(III) attached 
to either carboxylate oxygen or terminal amino nitrogen atom 
in no-histidine-containing peptides.23 On the basis of 
spectroscopic measurements, it was found that coordination 
of L-histidine-containing peptides stabilizes Au(III) ion and 
prevents its reduction to the Au(I)/Au(0) under physiological 
conditions.24  
Gold species have found their application in chrysotherapy, 
whereby complexes containing gold in the oxidation state +1 
are applied to reduce inflammation and disease progress in 
patients with rheumatoid arthritis.25,26  Clinically approved 
gold(I) complex, auranofin (2,3,4,6-tetra-o-acetyl-1-thio-β-D-
glucopyranosato-S-(triethylphosphine)gold(I)), utilized in 
therapy of severe rheumatoid arthritis since 1985, has also 
shown anticancer potential27 and was recently proven to be 
potent antimicrobial agent for the treatment of staphylococcal 
infections.28 Furthermore, it was found that auranofin exerts 
broad-spectrum bactericidal activities by targeting thiol-redox 
homeostasis in species such as Mycobacterium tuberculosis, 
Bacillus subtilis, Enterococcus faecium and methicillin-resistant 
Staphylococcus aureus.29 Recent study has also described 
auranofin as potent antiangiogenic compound.30  
It has been postulated that under physiological conditions, 
gold(I) species are more stable than the gold(III) ones, which 
are readily reduced to Au(I) and/or Au(0) by naturally 
occurring thiols and thioethers and various proteins.26,31,32 
Methionine oxidation to its sulfoxide in the presence of Au(III) 
has been evidenced by X-ray diffraction analysis.33 The fact 
that Au(III) can act as relatively strong oxidizing agent has been 
connected to its inhibiting activity of various proteins.25 The 
importance of coordination chemistry of Au(III) ion with L-
histidine-containing peptides, and the finding that some of 
these complexes have shown promising cytotoxic activity 
toward different human tumor cell lines,24 prompted us to 
study a series of gold(III) complexes with X-L-His dipeptides (X 
= Gly, L-Ala, L-Val and L-Leu), [Au(Gly-L-His-NA,NP,N3)Cl]Cl
.3H2O 
(1a), [Au(Gly-L-His-NA,NP,N3)Cl]NO3
.1.25H2O (1b), [Au(L-Ala-L-
His-NA,NP,N3)Cl][AuCl4]
.H2O (2a), [Au(L-Ala-L-His-
NA,NP,N3)Cl]NO3
.2.5H2O (2b), [Au(L-Val-L-His-
NA,NP,N3)Cl]Cl
.2H2O (3), [Au(L-Leu-L-His-NA,NP,N3)Cl]Cl (4a) 
and [Au(L-Leu-L-His-NA,NP,N3)Cl][AuCl4]
.H2O (4b). Part of this 
data, including the crystal structures of 1a, 1b and 2b, has 
already been reported.19,20 Nevertheless, all seven complexes 
have been evaluated for their antimicrobial and cytotoxic 
properties, while the ones that showed the best selectivity 
index have been evaluated using zebrafish (Danio rerio) 
embryos for toxicity and antiangiogenic potential and their 
activity has been compared to that of the corresponding 
dipeptides, K[AuCl4] and auranofin. In addition, in silico study 
was conducted to evaluate the potential of these complexes to 
bind both human and Escherichia coli thioredoxin reductases 
(TrxRs). 
Results and discussion 
 
Synthesis and spectroscopic characterization of the gold(III) 
complexes with L-histidine-containing dipeptides 
Synthesis. Seven gold(III) complexes with L-histidine-
containing dipeptides, [Au(Gly-L-His-NA,NP,N3)Cl]Cl
.3H2O (1a), 
[Au(Gly-L-His-NA,NP,N3)Cl]NO3
.1.25H2O (1b), [Au(L-Ala-L-His-
NA,NP,N3)Cl][AuCl4]
.H2O (2a), [Au(L-Ala-L-His-
NA,NP,N3)Cl]NO3
.2.5H2O (2b), [Au(L-Val-L-His-
NA,NP,N3)Cl]Cl
.2H2O (3), [Au(L-Leu-L-His-NA,NP,N3)Cl]Cl (4a) 
and [Au(L-Leu-L-His-NA,NP,N3)Cl][AuCl4]
.H2O (4b) were 
synthesized according to the procedure presented in Scheme 
1. The corresponding X-L-His dipeptide (X = Gly, L-Ala, L-Val 
and L-Leu) was mixed with an equimolar amount of K[AuCl4] in 
water at the pH range 1.50 – 2.00 and room temperature. We 
have found previously that the rate of the reaction between 
the corresponding dipeptide and Au(III) increased with 
increasing the pH of solution.23 However, when this reaction 
was performed at pH > 3.00, a reduction of Au(III) to Au(I) and 
Au(0) occurred during time. pH of the reaction mixture was 
adjusted by addition of 1 M HCl for 1a, 2a and 4a or 1 M HNO3 
for 1b, 2b and 4b, while in the reaction of L-Val-L-His dipeptide 
with K[AuCl4], complex 3 was formed in the presence of both 
acids. The stoichiometries of all gold(III) complexes were 
confirmed by elemental microanalysis, and their structures 
were elucidated by 1H NMR, IR and UV-vis spectroscopy. 
Proton NMR spectroscopic data of these complexes were 
correlated with those reported previously for 1b and 2b.20 The 
crystal structures of complexes 2a, 3, 4a and 4b were 
determined by single-crystal X-ray diffraction analysis. 
1
H NMR characterization. Ambient temperature 1H NMR 
spectra of gold(III) complexes 1-4 and the corresponding L-
histidine-containing dipeptides have been measured in D2O at 
pD 2.95. The 1H chemical and Δ(1H)coord coordination shifts for 
1a, 2a, 3 and 4a, determined in respect to those for the free 
peptides, are listed in Table 1. The proton NMR data of the 
complexes 1b, 2b and 4b are almost identical to those of the 
corresponding 1a, 2a and 4a, considering the fact that they 
differ only in the counter anion (Scheme 1). Furthermore, 
these data for the complexes 1b and 2b are in accordance with 
those reported previously for the same complexes, which 
structures have been determined by single-crystal X-ray 
diffraction analysis.20 
In the aromatic region, 1H NMR spectra of the complexes 
1a, 2a, 3 and 4a consist of two resonances corresponding to 
the C2H and C5H protons of the imidazole ring, with the 
chemical shifts slightly differing from those of the 
uncoordinated X-L-His dipeptides (Table 1). Previous studies 
related to the reactions of metal ions with this type of 
peptides have shown that the chemical shifts of the C2H and 
C5H imidazole protons are very good indicating parameters for 
binding of the metal center to the N3 or N1 imidazole nitrogen 
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atom.34 As can be seen from Table 1, the resonances for C2H 
and C5H imidazole protons of the complexes 1a, 2a, 3 and 4a 
are upfield shifted with respect to those for the free 
dipeptides. The larger coordination shifts were observed for 
the C2H (Δδ = 0.06 – 0.08 ppm) with respect to the C5H proton 
(Δδ = 0.00 – 0.04 ppm); this indicates that the binding center 
for Au(III) is imidazole N3 nitrogen. Contrary to the observed 
upfield shifting of the aromatic imidazole protons in 1a, 2a, 3 
and 4a, the coordination of X-L-His dipeptides to the Au(III) ion 
resulted in the downfield shifting of the aliphatic protons. 
However, as it was found previously for the complexes 1b and 
2b,20 differences in the chemical shifts of the aliphatic protons 
for the gold(III) complexes and the corresponding X-L-His 
dipeptides are not significant and are caused by the 
coordination of the N3 imidazole-anchored Au(III) ion to the 
deprotonated peptide nitrogen NP and to the nitrogen atom of 
the terminal amino group NA. The most notable difference in 
the spectra of the complexes with respect to those of the free 
peptides is the magnetic non-equivalence of the HisβCH2 
protons (Table 1), as a consequence of the six-membered 
N3,NP-ring formation (Scheme 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1 Schematic presentation of the synthesis of gold(III) complexes with L-histidine-containing dipeptides. The numbering of atoms in the imidazole ring follows 
the IUPAC rules. n represents the number of crystalline water molecules. 
Table 1 
1H chemical and coordination shifts (in parentheses), alongside multiplicities and coupling constants (JH-H), for X-L-His dipeptides (X = Gly, L-Ala, L-Val and L-Leu) and 
corresponding gold(III)-peptide complexes 1a, 2a, 3 and 4a in D2O as solvent with TSP as the internal standard measured at pD = 2.95. The NMR data of the complexes 1b, 2b and 
4b are almost identical to those of the corresponding 1a, 2a and 4a, respectively, and therefore not presented. s = singlet; d = doublet; dd = doublet of doublets; t = triplet; q = 
quartet; m =multiplet. 
IR and UV-vis characterization.
 The IR and UV-vis 
spectroscopic data for the gold(III) complexes with L-histidine-
containing dipeptides are listed in the Experimental section 
(vide infra) and are consistent with the structural formula 
presented in Scheme 1. The IR spectra of these complexes 
recorded in the range of 4000 – 450 cm-1 show the peaks that 
are attributed to the coordinated X-L-His dipeptides. The 
coordination of the dipeptides through the amino group of the 
N-terminal amino acid leads to the disappearance of the bands 
in the range of 1660 – 1590 and 1550 – 1480 cm-1 which are 
Au(III) complex pH adjustment X R Y
-
 n 
1a HCl Gly H Cl- 3 
1b HNO3 Gly H NO3
- 1.25 
2a HCl L-Ala CH3 [AuCl4]
- 1 
2b HNO3 L-Ala CH3 NO3
- 2.5 
3 HCl and HNO3 L-Val CH(CH3)2 Cl
- 2 
4a HCl L-Leu CH2CH(CH3)2 Cl
- 0 
4b HNO3 L-Leu CH2CH(CH3)2 [AuCl4]
- 1 
Peptide/Complex Imidazole  protons  
C2H (s)        C5H (s) 
Chemical shifts of other protons 
 GlyCH2   HisαCH HisβCH2 
Gly-L-His 8.62 7.31 3.84, s   4.67, t,  
J = 5.6 Hz 
3.27, m 
[Au(Gly-L-His-NA,NP,N3)Cl]Cl
.3H2O (1a) 8.56 
(-0.06) 
 
7.31 
(0.00) 
 
4.01, dd, 
J = 17.0, 3.8 Hz 
(+0.17) 
 
  4.72, t,  
J = 4.0 Hz 
(+0.05) 
3.12, dd, 
J = 15.8, 4.3 Hz 
3.60, dd, 
J = 15.8, 4.3 Hz (+0.09) 
 AlaαCH AlaβCH3  HisαCH HisβCH2 
L-Ala-L-His 8.62 7.31 4.08, q,  
J = 7.1 Hz 
1.52, d,  
J = 7.2 Hz 
 4.63, t,  
J = 7.0 Hz 
3.26, m 
[Au(L-Ala-L-His-NA,NP,N3)Cl][AuCl4]
.H2O (2a) 8.54 
(-0.08) 
 
7.29 
(-0.02) 
4.13, q,  
J = 7.2 Hz 
(+0.05) 
 
1.54, d,  
J = 7.2 Hz 
(+0.02) 
 4.64, t,  
J = 4.1 Hz 
(+0.01) 
3.12, dd, 
J = 15.7, 4.2 Hz 
3.57, dd, 
J = 15.7, 4.2 Hz (+0.085) 
 ValαCH ValβCH ValγCH3 HisαCH HisβCH2 
L-Val-L-His 8.63 7.33 3.90, d,  
J = 5.6 Hz 
2.24, m 1.01, dd,  
J = 6.6, 3.8 Hz 
4.57, t,  
J = 6.8 Hz 
3.26, m 
[Au(L-Val-L-His-NA,NP,N3)Cl]Cl
.2H2O (3) 8.55 
(-0.08) 
7.29 
(-0.04) 
3.98, d,  
J = 3.3 Hz 
(+0.08) 
2.35, m 
(+0.11) 
1.05, dd,  
J = 19.1, 7.1 Hz 
(+0.04) 
4.65, t,  
J = 3.8 Hz 
(+0.08) 
3.10, dd, 
J = 15.9, 4.0 Hz 
3.57, dd, 
J = 15.9, 4.0 Hz (+0.075) 
 LeuαCH LeuβCH2 
LeuγCH  
LeuδCH3 HisαCH HisβCH2 
L-Leu-L-His 8.63 7.32 4.00, t,  
J = 7.0 Hz 
1.68, m 0.93, dd,  
 J = 6.4, 1.6 Hz 
4.62, t,  
J = 7.0 Hz 
3.28, m 
[Au(L-Leu-L-His-NA,NP,N3)Cl]Cl (4a) 8.55 
(-0.08) 
7.30 
(-0.02) 
4.08, t,  
J = 6.8 Hz 
(+0.08) 
1.80, m 
(+0.12) 
0.97, t,  
J = 5.9 Hz 
(+0.04) 
4.67, t,  
J = 4.0 Hz 
(+0.05) 
3.12, dd, 
J = 16.1, 4.1 Hz 
3.58, dd, 
J = 15.1, 3.4 Hz (+0.07) 
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due to the antisymmetric and symmetric bending vibrations of 
the NH3
+ group in zwitterion form. The amide fragment bands 
in the IR spectra of the uncoordinated dipeptides are found to 
be at  ̴ 3200 cm-1 (νNH), in the 1690 – 1640 cm
-1 region (νC=O, 
amide I) and at   ̴ 1550 cm-1 (δNH, amide II).
35 However, the 
bands assigned to stretching and bending modes of NH group 
are absent in the IR spectra of the gold(III) complexes, 
indicating that coordination of the Au(III) ion to the amide 
nitrogen was accompanied by its deprotonation. Moreover, 
the coordination of the deprotonated amide nitrogen results 
in the shifting of amide I νC=O frequencies to the lower values 
with a difference within 19 – 67 cm-1 compared to the free 
ligands (at 1691, 1659, 1669 and 1670 cm-1 for Gly-L-His, L-Ala-
L-His, L-Val-L-His and L-Leu-L-His, respectively). Finally, the 
presence of the strong bands in the range of 1750 – 1700 cm-1 
in the IR spectra of the complexes are due to the 
antisymmetric stretching vibrations of C=O in the protonated 
carboxyl group,36 and additionally confirms that the oxygen 
atom of this group does not participate in the coordination 
with Au(III) ion. 
The shape of the UV-vis spectra and values of λmax are 
almost identical for all investigated complexes, indicating the 
same coordination mode of X-L-His dipeptides. The absorption 
around 280 nm observed for the complexes corresponds to 
LMCT (ligand-to-metal charge transfer) transitions.37 The 
intensity of absorption maxima for complexes 2a and 4b is 
approximately twice as high as for the other investigated 
gold(III)-peptide complexes, which can be attributed to the 
presence of [AuCl4]
- counter anion in the crystals of these two 
complexes.   
 
Crystallographic characterization of the gold(III) complexes 
with L-histidine-containing dipeptides 
Composition of the complexes. The X-ray crystal structure 
analysis of the complexes 2a, 3, 4a and 4b allowed us to 
establish the content of the samples and to perform full 
structural characterization of the homologous series of the 
gold(III) complexes with L-histidine containing dipeptides by 
comparing the obtained results with the available literature 
data for complexes 1a, 1b and 2b,19,20 taking into account the 
influence of the counter anion and water molecules. As far as 
the composition of the samples is concerned, the most 
obvious difference between the gold(III) complexes with Gly-L-
His and L-Ala-L-His peptides on one side, and L-Val-L-His and L-
Leu-L-His on the other side is that we have not been able to 
incorporate the nitrate groups as the counter ions into the 
crystal lattice of the latter two complexes. Another 
unexpected effect is an appearance of tetrachloridoaurate(III) 
salts of [Au(L-Ala-L-His-NA,NP,N3)Cl]
+ and [Au(L-Leu-L-His-
NA,NP,N3)Cl]
+  complexes instead of the expected nitrate and 
chloride salts. Complex 3 crystallizes with two symmetry 
independent, though geometrically similar, structural units 
(Z’=2), while the other three crystals (2a, 4a and 4b) contain 
one formal molecule in the asymmetric part of the unit cell 
(Z’=1). 
Environment of the Au(III) ion in complex cations. In 
principle the Au(III) ion has coordination number four, which 
however, in 2a and 4b is extended to five, and in 3 to six by 
weak Au···Cl interactions (vide infra). Au(III) ion is bound to 
one dipeptide molecule via three nitrogen atoms of the amino, 
peptide and imidazole groups. The fourth bond joins the Au(III) 
ion to the chloride ligand. This is illustrated for the newly 
investigated complexes 2a, 3, 4a and 4b in Fig. 1. The bond 
lengths and angles for these complexes are shown in Table S1, 
which also lists the corresponding parameters in comparable 
structures, i.e. 1a,19 1b and 2b.20 The Au—N bonds have 
lengths in the range of 1.91(1) to 2.03(1) Å with no particular 
distinction to which of the three nitrogen atoms they are 
formed. The angle N1—Au1—N2 (within the five-membered 
ring) has values in the range from 80.8(4) to 84.8°, while the 
one within the six-membered ring i.e. N3—Au—N2 spreads the 
values from 90.9 to 95.7(4)°. It is important to note that the 
numbering of the atoms used in this section does not match 
the one applied in the NMR studies, reported above. Marked 
deviations in angles around the metal from the ideal 180° 
valence angle are more severe for N2—Au1—Cl1 than for N1—
Au1—N3, covering the range from 171.7(2) to 174.7(3)°. This 
angle involves a peptide nitrogen which is a member of six- 
and five-membered chelate rings, so the smaller than expected 
value for this angle, might be the result of the requirement 
that the three bonds around the peptide nitrogen remain 
approximately coplanar. The peptide groups C1—C2—O1—
N2—C3, the imidazole groups C5—C6—N4—C7—N3, and the 
carboxyl groups C3—C8—O2 and O3 are planar within the 
limits of accuracy. The five-membered chelate rings —Au—
N1—C1—C2—N2— in 1a and 4a complex cations are planar 
(see Table S2 for a list of endocyclic torsion angles). They 
become somewhat puckered in two independent molecules of 
3 (the average endocyclic torsion angle moduli │ω│being equal 
to 10.8(4.4) and 11.5(5.6)°, respectively) with the peptide 
nitrogen atom deviating the most from the ring main plane. 
Within a series of chloride salts (1a, 3 and 4a) the slight 
increase of the ring puckering in 3 and its absence in 4a might 
mirror a difference in steric hindrance between the bulky 
isopropyl group directly bonded to C1 (3) or bonded to C1 via 
the methylene bridge (4a), but it may well result from an 
engagement of the complex cations of 3 in self-assembly by 
means of Au···Cl interactions (vide infra). In contrast to the 
chloride salts 1a, 3 and 4a, in which the five-membered 
chelate ring is planar or nearly so, the nitrate salts 1b and 2b20 
display the most puckered five-membered chelates, where the 
average endocyclic torsion angle moduli span the values of 
13.1(4.9), 17.1(9.2) and 20.3(7.9)° (three independent 
observations) and with either Au1 or both Au1 and N1 
deviating from the ring main plane. In the 
tetrachloridoaurate(III) salts 2a and 4b, the degree of the five-
membered chelate ring puckering is intermediate between the 
two discussed extremes with the average torsion angle moduli 
of 9.8(4.5) and 14.6(6.3)°, respectively. Noticeably higher ring 
puckering in 4b compared with 2a illustrates the effect of the 
replacement of the C1-metyl group by the iso-butyl 
substituent. Taken together, it looks as though planarity of the 
five-membered chelate ring in the investigated series of 
structures not only depends on the substitution on C1, which is 
to be expected, but also, to even bigger extent, on the type of 
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the counter anion and imposed by it the mode of association 
of the complex cations in crystals. The conformation of the six-
membered chelate rings is described in terms of the endocyclic 
torsion angles listed in Table S2. The conformation is highly 
distorted from any of the ideal forms. In majority of structures, 
it can best be described as 1,3-diplanar with the histidine Cα 
and Cβ below and above the plane defined by the remaining 
atoms. However, in some structures (one of the two 
independent molecules of 1b), the ring approaches a sofa 
conformation with the histidine Cβ (C4 according to the 
crystallographic numbering scheme) out of the plane of the 
other five atoms. The angle between the planes of the 
imidazole ring and the coordination square takes the values 
from 6.3(4) to 24.8°. The carboxyl group adopts an axial 
orientation with respect to the coordination plane and the 
plane of the carboxyl group (C-COO) forms angles in the range 
from 76.8(4) to 89.1° and from 59.4(5) to 82.0(3)° with the 
planes of the coordination square and the imidazole group. 
Environment of the Au(III) ion in tetrachloridoaurate(III) 
anion. Bond lengths within the tetrachloridoaurate(III) anion 
well mirror the engagement of particular chlorine atoms in 
intermolecular interactions. The involvement in multiple 
intermolecular interactions leads to significant lengthening of 
the Au—Cl bond. This is exemplified by Au—Cl2 and Au—Cl5 
bond lengths in crystals of 2a which measure 2.294(3) and 
2.283(3) Å, while the remaining two bonds are 2.267(3) and 
2.262(3) Å. Similarly, in the crystal of 4b, the Au—Cl bond 
lengths to chlorine atoms involved in intermolecular 
interactions are 2.270(2), 2.280(3) and 2.283(3) Å, while the 
analogous bond to the chlorine atom that does not participate 
in intermolecular interactions is much shorter (2.258(3) Å). 
Such clear correspondence between bond lengths and 
intermolecular interactions is rarely observed, as the change of 
the bond length requires relatively high energy expenditure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1 Ellipsoid representation of complex cations present in the crystals of 2a, 3 (one of two crystallographically independent molecules), 4a and 4b. Displacement 
ellipsoids are drawn at 40% probability level. The hydrogen atoms are presented in an arbitrary scale. 
The role of the particular functional groups in 
intermolecular interactions. Geometrical parameters 
describing hydrogen bond interactions in seven crystal 
structures of gold(III) complexes with L-histidine-containing 
dipeptides are presented in Table S3. Because of the presence 
of the L-histidine residue in all investigated crystal structures, 
the involvement of imidazole ring in hydrogen bonding might 
be of special interest. It appears that both N-H and C-H donors 
are engaged in hydrogen bonding. Most remarkable is a short 
C-H···O hydrogen bond from C7-H to the peptide or 
carboxylate C=O, which supports the self-association of 
cationic species. Meanwhile, the N-H(imidazole) functionality 
is nearly always utilized for the purpose of communication 
with the anionic species, the only exception being the highly 
hydrated complex 1a, in which the imidazole nitrogen acts as a 
hydrogen bond donor to one of the water molecules.  
Having two hydrogen bond donor groups, the amine group 
utilizes at least one of them to bind to a counter ion and/or to 
a water molecule. If the other hydrogen atom is used for the 
self-assembly of the complex cationic species, it binds to a 
peptide (1b, 2a) or to a carboxyl C=O group (4a). This type of 
peptide-peptide interactions is seen in the docking studies 
described below.  
The carboxyl group preferentially binds to water molecules 
by utilizing either its proton donor or proton acceptor ability or 
both. In non-hydrated species, it donates hydrogen bonds to 
the counter anions (Cl– or NO3
–). However, the H-bond 
donation to the nitrate group forces the carboxyl group to 
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change its conformation from the preferred syn to anti, which 
is rare in crystal structures containing the carboxyl 
functionality.20 Only in [Au(L-Leu-L-His-NA,NP,N3)Cl]
+ 
complexes (4a and 4b), the carboxyl group is being utilized in 
self-assembly of the cationic species, either as a hydrogen 
bond donor to a peptide carbonyl group (4b) or as a hydrogen 
bond acceptor from the amine NH functionality (4a), again 
resembling the peptide-peptide interactions seen in the 
docking studies (vide infra). 
As one can observe in the non-hydrated crystals of 4a, the 
peptide carbonyl group may be excluded from the process of 
formation of strong intermolecular hydrogen bonds, 
presumably due to the lack of the sufficient amount of the 
hydrogen bond donor groups. Instead, the group is involved in 
weak both inter- and intramolecular hydrogen bonds that 
involve CH groups as donors. The intramolecular C*-H···O(=C) 
hydrogen bond (2.32 Å, 2.728(9) Å and 104° for H···O, C···O 
and C-H···O, respectively) can also be classified as CH/CO 
dipolar interaction, where the pseudo-torsion angle between 
the pair of the C*-H/C=O dipoles situated in respective 1,3-
positions amounts to 18°. In the remaining crystal structures, 
deprived of this type of dipolar interactions, the pseudo-
torsion angle between the two dipoles adopts much higher 
values, which cover the range from 27 to 42°. Characteristics 
of Au(III) complexes with chloride ligands are the Au···Cl 
intermolecular interactions that usually supplement the 
square-planar coordination around the Au(III) cation to five or 
six. As mentioned previously, this kind of interactions, 
although weak, was present in the crystal structures of nitrate 
salts (1b and 2b).20 In these crystals the Au···Cl interactions, 
formed between the complex cations, extended through the 
entire crystal in a form of chain or ladder motifs. It may look as 
though the presence of the tetrachloridoaurate(III) anion, 
possessing four Au—Cl bonds, increases a chance for the 
occurrence of the Au···Cl interactions. They are indeed present 
and quite strong in the crystals of the tetrachloridoaurate(III) 
salts 2a and 4b but, unlike in the nitrate salts, they act 
between pairs of complex cations and anions, extending the 
coordination number of Au(III) to five. These discrete Au···Cl 
interactions gain additional support from the amine NH group, 
which is engaged in NH···Cl hydrogen bonding to one of the 
chloride atoms of the same tetrachloridoaurate(III) complex 
anion that is involved in Au···Cl interactions with the complex 
cation (Fig. 2). In 2a, the Au···Cl contacts measure 3.496(3) and 
3.284(2) Å, while in 4b, a single Au···Cl distance amounts to 
3.371(3) Å. These values can be compared with the sum of the 
van der Waals radii for Au and Cl atoms equal to 3.41 Å.38 In 
dihydrated crystals of 3, two symmetry independent complex 
cations associate with Au···Cl interactions that extend through 
the entire crystal forming a ladder motif and supplement the 
square-planar coordination around Au(III) to an elongated 
tetragonal octahedron. This is illustrated in Fig 3. Interestingly, 
this kind of interaction is absent in the crystals of other 
chloride salts of gold(III) complexes with either Gly-L-His (1a) 
or L-Leu-L-His (4a) dipeptides, but has been observed in all 
crystal forms of the nitrate salts of gold(III) complexes with 
Gly-L-His (1b) and L-Ala-L-His (2b).20 In the crystals of 3, the 
Au1···Cl2 contacts amount to 3.533(2) and 3.456(2) Å, while 
the analogous Au2···Cl1 distances are 3.436(2) and 3.595(2) Å. 
Notably, crystals of 3 display the biggest variety of 
intermolecular interactions. Besides the already mentioned 
Au···Cl interactions and the various types of hydrogen bonds, 
in these crystals there are π···π interactions between pairs of 
parallel imidazole rings belonging to the symmetrically 
independent molecules. The two rings are inclined at an angle 
of 6.9(4)° and the distance between the gravity centers of the 
two rings amounts to 3.38 Å. 
Water molecule is by all means a mediator. For example, in 
2a it bridges two distant amine and carboxyl groups of the 
same complex cation by engaging to this process the peptide 
oxygen from the neighboring molecule. Simultaneously, by 
accepting a hydrogen bond from another complex cation the 
water molecule mediates in joining together solely the 
complex cations. But much more often, if present in the crystal 
lattice, water molecule mediates in joining together the 
cationic and anionic species. In the absence of crystalline 
water molecules (4a), the complex cations utilize the proton 
donor properties of amine, carboxyl and NH-imidazole to link 
all these functionalities to a single counter ion.  
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Fig. 2 Pairwise and single Au···Cl interactions between complex cations and anions in crystal structures of 2a and 4b, respectively, supported by NH···Cl hydrogen 
bonds.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 The arrangement of Au–Cl dipoles (represented as balls and sticks) into a 
ladder motif in the crystal of 3. Hydrogen atoms have been omitted for clarity. 
Biological activity of the gold(III) complexes with L-histidine-
containing dipeptides 
Antimicrobial and cytotoxic activity. Prompted by the 
recent reports of efficient and broad-spectrum antimicrobial 
activity of auranofin28,29 and various gold(I) and gold(III) 
complexes,39 we have examined the antimicrobial potential of 
the synthesized gold(III) complexes with L-histidine-containing 
dipeptides. The antimicrobial activities of the gold(III) 
complexes with L-histidine-containing dipeptides X-L-His (X = 
Gly, L-Ala, L-Val and L-Leu), namely 1a, 1b, 2a, 2b, 3, 4a and 4b, 
the starting K[AuCl4] and auranofin were evaluated against the 
broad panel of Gram-positive (Staphylococcus aureus, Lysteria 
monocytogenes, Enterococcus faecalis and Enterococcus 
faecium) and Gram-negative  (Acinetobacter baumannii) 
bacteria and two strains of Candida (C. albicans and C. 
parapsilosis), while their cytotoxic properties were evaluated 
against one normal (MRC5, human lung fibroblasts) and two 
cancer cell lines (HeLa, human cervix cancer, and A549, human 
lung cancer) (Table 2).  
While the antibacterial activity was confirmed for the 
auranofin with MIC (minimal inhibitory concentration) values 
between 1-10 µM, the most MIC values of the gold(III) 
complexes with L-histidine-containing dipeptides were 
between 200 and 400 µM, indicating their moderate to low 
activity. However, 1b and 4b exhibited MIC of 80 µM against 
Gram-positive E. faecium and 100 µM against Gram-negative 
A. baumannii (Table 2). The obtained results were in 
agreement with our recent study related to the antimicrobial 
potential of a series of gold(III) complexes differing in the 
ligand structure, i.e. [HGly-Met sulfoxide][AuCl4] (Gly-Met is 
dipeptide glycyl-methionine), [Au(en)Cl2]Cl
.2H2O (en is 
ethylenediamine), [Au(dien)Cl]Cl2 (dien is diethylenetriamine), 
[Au(Gly-L-His-NA,NP,N3)Cl]NO3
.1.25H2O (complex 1b in the 
present study), [Au(L-Ala-L-His-NA,NP,N3)Cl]NO3
.2.5H2O 
(complex 2b in the present study) and [Au(Gly-Gly-L-His-
NA,NP1,NP2,N3)]Cl
.H2O (Gly-Gly-L-His is tripeptide glycyl-glycyl-
L-histidine), also showing that two gold(III) complexes with L-
histidine-containing dipeptides exhibited relatively weak 
effects compared to the others against the investigated 
bacterial strains, both ATCC and clinical isolates.40 The K[AuCl4] 
was the most active against S. aureus (MIC = 80 µM) and 
exhibited similar antibacterial activity to that of the 
investigated gold(III) complexes (Table 2). In the case of the 
fungi, C. parapsilosis was more sensitive to the investigated 
gold(III) complexes in comparison to C. albicans; nevertheless, 
all MIC values against the fungi were relatively high, except the 
ones for auranofin (MIC = 10 µM). Greater sensitivity of C. 
parapsilosis may be of some interest, as this strain had shown 
steady incline in prevalence, causing severe infections in 
neonates and patients in intensive care units.41 Under the 
tested conditions, none of the L-histidine-containing 
dipeptides was toxic towards the investigated strains in 
concentrations up to 500 µM.  
 
Table 2 Antimicrobial activity expressed as MIC (µM)a and cytotoxic activity expressed as IC50 value (µM)
b for all gold compounds used in this study. L-Histidine-containing 
dipeptides had no observable activities at concentrations > 500 µM. 
 
Complex 1a 1b 2a 2b 3 4a 4b K[AuCl4] Auranofin 
Microorganism 
S. aureus  
NCTC 6571 
         
300 300 200 400 400 300 300 80 5 
L. monocytogenes 
NCTC 11994 
200 200 100 200 200 200 200 100 10 
E. faecalis  
ATCC 29212 
200 200 200 200 200 200 200 200 1.25 
E. faecium  
ATCC 6057 
200 80 200 200 200 200 80 200 2.5 
A. baumannii  
ATCC 19606 
100 100 100 100 100 200 100 100 2.5 
C. albicans 
ATCC 10231 
400 500 400 400 500 200 400 100 10 
C. parapsilosis  
ATCC 22019 
200 200 200 400 400 100 200 200 10 
Cell line         
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MRC5 > 200 > 200 150 > 200 > 200 170 100 150 0.9 
HeLa 150 > 200 75 170 > 200 55 65 170 0.5 
A549 150 > 200 30 170 > 200 115 75 160 0.5 
aThe MIC values were determined in duplicates in three independent experiments. SD were within 2-5%. 
bIC50 is defined as the concentration inhibiting 50% of cell growth after the treatment with the test compounds.  Results are from three independent experiments, each performed 
in quadriplicate. SD were within 2-5%. 
 
Like in this study, only moderate activity against bacteria 
and fungi was found for the organometallic gold(III) 
thiosalicylate complex,42 as well as for most of the 
organogold(III) complexes containing imidate43 and 
bis(amidate) ligands.44 On the other hand, mononuclear 
gold(III) complexes with aromatic nitrogen-containing 
heterocycles of the general formula [AuCl3(N-heterocycle)] (N-
heterocycle is pyridazine, pyrimidine, pyrazine, quinoxaline 
and phenazine)45 and dinuclear {[AuCl3]2(µ-L)} complexes (L 
stands for 4,4’-bipyridine and 1,2-bis(4-pyridyl)ethane)46 
exhibited slightly better activity against the investigated 
bacterial and fungal strains than the presently investigated 
gold(III)-dipeptide complexes. Moreover, organometallic 
complexes [AuCl2(damp)], [Au(CH3COO)2(damp)] and 
[AuCl2(ppy)] (damp is 2-((dimethylamino)methyl)phenyl and 
ppy is 2-pyridylphenyl) showed a broad-spectrum and good to 
excellent antimicrobial activity against different strains, with 
some preference for Gram-positive bacteria, S. aureus and E. 
faecalis.47,48 
Rationale behind the numerous efforts to develop 
cytotoxic agents based on gold(III) is the fact that Au(III) ion is 
isoelectronic with Pt(II), and its complexes usually adopt the 
square planar geometry similar to the clinically utilized 
platinum-based agents cisplatin and carboplatin.49,50 
Surprisingly, most of the studied gold(III) complexes showed 
modest binding activity to double stranded DNA, and exhibited 
relatively high reactivity towards various proteins.51,52 Our 
present results confirm the cytotoxic potential of auranofin 
with IC50 values in accordance to the previous studies on the 
same cell lines.53 However, the cytotoxic effect of the most 
active of the studied gold(III) complexes with L-histidine-
containing dipeptides, 2a, was from 60 to 170-fold lower in 
comparison to that of auranofin, for A549 and MRC5 cell lines, 
respectively (Table 2). Complexes 3 and 1b exhibited no 
detectable toxicity in concentrations up to 400 µM and thus 
their IC50 values were denoted as > 200 µM (Table 2). 
Complexes 2a, 2b, 4a and 4b showed some selectivity between 
the normal fibroblasts MRC5 and human cervical cancer (HeLa) 
and adenocarcinomic human alveolar basal epithelial cells 
(A549). Lower cytotoxic effects or their complete lack are 
actually in line with the comparable studies, where 1a was 
reported to exhibit cytotoxic effect upon prolonged exposure 
of 72 h with ovarian carcinoma cell line A2780/S and A2780/R 
(IC50 of 5.2 and 8.5 µM) and IC50 values of more than 120 µM 
upon shorter exposure times.24 Furthermore, IC50 values 
determined for gold(III)-dipeptide complexes are similar to the 
ones reported for [Au(dien)Cl]Cl2 and [Au(cyclam)](ClO4)2Cl 
(cyclam is 1,4,8,11-tetraazacyclotetradecane) from the 
systematic study conducted on the panel of 12 cell lines.52 It is 
worth mentioning that the [Au(dien)Cl]Cl2 complex has the 
same N3Cl coordination sphere as the complexes presently 
investigated, while in the [Au(cyclam)](ClO4)2Cl, the 
corresponding ligand is coordinated to Au(III) ion through four 
nitrogen atoms. Moreover, similar to our study, a negligible 
cytotoxicity on the A549 cell line was previously observed for 
[Au(bipydmb-H)(OH)][PF6], [Au(bipy
dmb-H)(2,6-xylidine-H)][PF6], 
[Au(bipydmb-H)(p-toluidine-H)][PF6] (bipy
dmb = 6-(1,1-
dimethylbenzyl)-2,2’-bipyridine), [Au(pydmb-H)(AcO)2] (py
dmb = 
2-(1,1-dimethylbenzyl)-pyridine) and K[Au(pzPh-H)Cl3] (pz
Ph = 1-
phenylpyrazole) complexes with IC50 values ≥ 35 µM.
54 On the 
other hand, gold(III) complexes containing dithiocarbamates, 
[Au(dmdt)Cl2], [Au(dmdt)Br2] (dmdt = N,N-
dimethyldithiocarbamate), [Au(esdt)Cl2] and [Au(esdt)Br2] 
(esdt = ethylsarcosinedithiocarbamate), have been proved to 
be very active on the HeLa and A549 cell lines, with IC50 values 
falling in the low micromolar or even nanomolar range.55 
Overall, gold(III) complexes with L-histidine-containing 
dipeptides are not potent antimicrobials and do not have great 
anticancer potential, however their low cytotoxicity towards 
normal cell line makes them suitable candidates for further 
examination towards other activities including 
antiinflammatory, antiangiogenic or for utilization in the 
combination therapy.  Therefore, complexes that did show 
some antimicrobial properties and selectivity in terms of 
cancer vs. normal cell lines (2a, 2b, 4a and 4b) were brought 
forward for in vivo studies on zebrafish embryo model. 
Embryotoxicity and antiangiogenic potential. Zebrafish is 
recognized as a reliable and versatile in vivo platform for early 
drugs’ safety evaluation.56 The in vivo toxicity assessment 
performed in this study showed that gold(III) complexes with 
L-histidine-containing dipeptides 2a, 2b, 4a and 4b were 
markedly less toxic (lethal and teratogenic) to zebrafish 
embryos in comparison to auronofin, ranking them as follow: 
auranofin > 2a > K[AuCl4] > 2b > 4b > 4a.  Based on the 
determined LC50 concentration values, auranofin was between 
3 and 33-fold more toxic in comparison to the gold(III) 
complexes 2a and 4a, respectively (Fig. 4). Our results 
confirmed the embryotoxicity of auranofin in accordance with 
the previous studies on zebrafish embryos model,57,58 showing 
serious cardiovascular and skeletal defects in the embryos 
exposed to doses ≥ 2.5 µM, and 100% mortality rate of the 
embryos at doses ≥ 7.5 µM during 114 h treatment (Fig. 4). On 
the other side, embryos treated with gold(III) complexes had 
no developmental defects at doses up to 100 µM, except for 
the case of 2a treatment. Complex 2a, although with the 
lowest LC50 of 11.6 µM, caused pericardial edema in embryos 
at each of tested concentrations, which survived up to 114 hpf 
(hours post fertilization). Complexes 2b and 4b had 
comparable LC50 concentration values of close to 60 µM, while 
K[AuCl4] was more toxic (LC50 = 47 µM) than 2b, 4a and 4b, and 
without adverse developmental effects. Interestingly, embryos 
upon treatment with each of the complexes had reduced or 
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absent caudal circulation, similarly to the pattern observed in 
embryos upon auranofin treatment. These complex-treated 
embryos had neither developmental defects (except of those 
treated with 2a) nor body necrosis, which develops upon 
treatment with auranofin (Fig. 4). It has been observed that 
complexes 2a, 4a and 4b interfered embryos hatching, like 
auranofin, but with different final outcome (Fig. 4). While 
auranofin-treated embryos have already been prevented for 
hatching at 2.5 µM and all unhatched embryos died up to 114 
hpf, the unhatched embryos upon tested concentrations range 
of 2a (12.5 - 100 µM) survived up to 114 hpf. On the other 
hand, 4a and 4b inhibited embryos hatching only at ≥ 50 µM, 
where all unhatched embryos upon 4a treatment survived up 
to 114 hpf without observable deformities and cardiovascular 
defects, while majority of those upon 4b died in a period 
between 96 hpf and 114 hpf (Fig. 4). In comparison to the 
corresponding LC50 values of gold(III) complexes with aromatic 
nitrogen-containing heterocycles that have previously been 
addressed in the zebrafish embryos,45 gold(III) complexes with 
L-histidine-containing dipeptides explored in this study showed 
up to 5.2-fold less toxicity. Inhibition of embryos hatching has 
been observed for both groups of gold(III) complexes, 
suggesting that observed effect on the hatching may be 
attributed to the Au(III) ions. Recently, Lin et al.59 
demonstrated that some free metal ions released from metal-
oxide nanoparticles could bind to the active site of Zn-
metalloproteases, enzymes involved in the hatching process, 
and thus may inhibit their activity and hatching success. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4 Results of the toxicity assay on zebrafish embryos exposed to gold(III) complexes 2a, 2b, 4a and 4b, K[AuCl4] and auranofin expressed as LC50 values (µM). 
Morphology of zebrafish embryos at 114 hpf after treatment with 75 µM of 2a (unhatched teratogenic), 2b (normal), 4a (normal), 4b (unhatched embryos dead in a 
period from 96-114 hpf), K[AuCl4] (dead) and 7.5 µM of auranofin (teratogenic) are shown. Dipeptides L-Ala-L-His and L-Leu-L-His had no toxic activity on zebrafish 
embryos at concentration up to 200 µM. Embryos upon 75 µM of 2a developed pericardial edema (arrowhead), while embryos upon 7.5 µM of auranofin were 
retarded in the growth, had small head with malformed eyes (bracket), large pericardial edema (arrowhead), non-resorbed egg yolk (asterisk) and necrotic tissue in 
the tail region (arrow). 
Based on our recent study on gold(III) complexes with 1,7- 
and 4,7-phenanthroline,60 and the pattern of reduced caudal 
circulation observed during the embryotoxicity assessment, we 
have decided to examine the ability of gold(III) complexes with 
L-histidine-containing dipeptides to affect angiogenesis in vivo 
in the zebrafish model. Angiogenesis plays an essential role in 
many physiological and pathological conditions including 
inflammatory diseases such as rheumatoid arthritis, psoriasis 
and cancer.61 It is defined as process of formation of new 
blood vessels from the preexisting ones,62 and thioredoxin 
reductase (TrxR) has been implicated in this process.63 The 
suppression effect on angiogenesis by complexes 2a, 2b, 4a 
and 4b has been verified in vivo using transgenic zebrafish 
[Tg(fli-1:EGFP)] embryos, in which the endothelial cells 
expressing EGFP can be directly observed by fluorescence 
microscope.  
The developmental angiogenesis in zebrafish embryos, 
leading to the formation of the intersegmental vessels (ISVs) at 
48 hpf, and subintestinal vessels (SIVs) at 72 hpf, represents a 
target for the screening of antiangiogenic compounds.64 The 
embryos upon treatment with different gold(III) complexes 
displayed different antiangiogenic phenotypes, while 0.1% 
DMSO and corresponding ligands had no effect on the 
formation of ISVs and SIVs which were developed as a basket-
like structure with 5 - 9 arcades (Fig. 5 and Fig. S1). The starting 
K[AuCl4] complex at 35 µM concentration had only weak effect 
on SIVs sprouting, while did not affected ISVs development. In 
the auranofin (1.25 µM) and sunitinib malate (1.25 µM) 
treated groups, that are known for their antiangiogenic 
activities, SIVs formation was almost totally inhibited, while 
some ISVs were defective or absent. In both cases, treated 
embryos suffered from serious pericardial edema (Fig. 5). The 
inhibition of SIVs formation was achieved by each of four 
gold(III)-dipeptide complexes in the dose-dependent manner, 
whereas 35 µM of 2a and 4b almost completely inhibited their 
development (Fig. S1). 
Reduced ISVs and disrupted dorsal longitudinal 
anastomotic vessels (DLAV) have been detected upon 2a (35 
µM) treatment, while 2b treated embryos showed thinner ISVs 
(Fig. 5). Embryos treated with 35 µM of 4a and 4b had 
markedly thinner ISVs then 0.1% DMSO-treated ones, and 
interrupted DLAV in some segments. Most of embryos 
possessing thinner ISVs had very slow (upon 25 µM 
treatments) or totally absent (upon 35 µM treatments) blood 
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circulation in the caudal region indicating that if vessels were 
initially developed, they were not functional. Notably, none of 
embryos exposed to complexes 2a, 2b, 4a and 4b suffered 
from pericardial edemas neither had disturbed heartbeating 
rate, as opposed to embryos treated with 1.25 µM auranofin 
and sunitinib malate (Fig. 4). 
Overall, gold(III) complexes with L-histidine-containing 
dipeptides showed antiangiogenic activity in vivo in zebrafish 
embryos model, where the complexes 2a and 4b had the 
highest antiangiogenic potential. Although gold(III) complexes 
achieved comparable antiangiogenic effect to auranofin and 
sunitinib malate at 30-fold higher concentration, zebrafish 
embryos upon gold(III) complexes treatment had no 
cardiovascular side effects in comparison to those upon 
treatment with auranofin and sunitinib malate, as shown in 
the angiogenesis assay. Moreover, overall embryotoxicity of 
gold(III) complexes was significantly lower in comparison to 
auranofin, proposing them to serve as leads for further 
development towards antiangiogenic drugs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5 In vivo effect of gold(III) complexes 2a, 2b, 4a and 4b in comparison to sunitinib malate (Suten), auranofin and K[AuCl4] on subintestinal vessels (SIVs), 
intersegmental vessels (ISVs) and dorsal longitudinal anastomotic vessels (DLAV) development in zebrafish embryos assessed at 48 hpf (for ISVs and DLAV) and 72 hpf 
(for SIVs). Normally developed SIVs, ISVs and DLAV are designated in 0.1% DMSO-treated embryo. Reduced SIVs (arrowhead), disrupted DLAV (asterisk), thinner or 
reduced ISVs (arrow), and pericardial edema (dashed arrow) are denoted. 
Molecular docking study. In the light of recent findings 
that auranofin and some gold(III) complexes may exert affinity 
through the inhibition of thioredoxin reductase (TrxR),29,65 and 
that this enzyme has been implicated in angiogenesis,63 we 
have performed molecular docking study using human and 
bacterial (E. coli) TrxRs as target macromolecules (Fig. 6). The 
determination of a suitable geometry and binding affinity of 
the studied complexes (auranofin and cationic part of the 
gold(III)-dipeptide complexes) to the active site of both 
receptors was done with the application of the scoring 
functions.66 The binding affinities and the energies for the 
investigated complexes were presented in Table S4. According 
to the results for HBond, the scoring function that describes 
hydrogen bond interactions between a given complex and the 
amino acids from the enzyme active site, for human TrxR the 
highest interaction was obtained for auranofin, while for E. coli 
TrxR the highest interaction was obtained for 1a/b. Similarly, 
according to NoHBond interactions, that are related to the 
other interactions between complex and amino acids from the 
enzyme active site, excluding steric and van der Waals 
interactions, the highest interaction was observed for 
auranofin and 1a/b for human and E. coli TrxR, respectively. 
Steric is the scoring function that describes steric interaction 
between a given complex and the amino acids from the 
enzyme active site. According to the obtained results for this 
function, the highest interaction for both human and E. coli 
TrxRs was obtained for auranofin. Furthermore, according to 
the obtained results for van der Waals interactions between a 
given complex and the amino acids from the enzyme active 
site (VdW function), the highest interaction was obtained for 
1a/b and auranofin for human and E. coli TrxR, respectively. 
According to the obtained results for the total energy of 
interactions between the complex and the amino acids from 
the enzyme active site (energy function), as well as both 
MolDock and Rerank scores, the highest potency was observed 
for auranofin for both human and E. coli TrxRs. Finally, 
according to the results for LE1 (complex efficiency defined as 
MolDock score divided by the heavy atoms count) and LE3 
(complex efficiency defined as Rerank score divided by the 
heavy atoms count), for both human and E. coli TrxRs, the 
highest efficiency was obtained for 1a/b.  
The best calculated poses for all studied complexes inside 
the active site of enzymes are presented in Fig. 6. The best 
docking pose for each studied complex individually is 
presented in ESI, as well as two-dimensional representation of 
their interactions with the amino acids inside the binding 
pocket of the enzyme with identified hydrogen bonds and 
hydrophobic interactions between the investigated complexes 
and amino acids from the enzyme’s active site (Fig. S2-S5). 
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Fig. 6 The best calculated poses for all studied gold(III) complexes and auranofin 
inside the active site of human a) and Escherichia coli b) thioredoxin reductases. 
Conclusions 
Seven gold(III) complexes with L-histidine-containing 
dipeptides were synthesized, structurally characterized by 
spectroscopy and crystallography and biologically evaluated. In 
all complexes, dipeptides are tridentate coordinated to the 
Au(III) ion through the N3 imidazole nitrogen, the 
deprotonated nitrogen of the amide bond and to the nitrogen 
of the N-terminal amino group. The presence of Au–Cl dipoles 
in the crystals creates conditions for their mutual interactions 
that supplement the square planar coordination around Au(III) 
to a strongly elongated square pyramid or tetragonal 
octahedron. These interactions are either isolated, involving 
pairs of cationic and anionic species, or extend through the 
entire crystal lattice in a form of chain or ladder motifs 
consisting solely of cationic species. Particularly suited for the 
extended Au···Cl dipolar interactions seem to be the nitrate 
salts. Besides that, the degree of the puckering of the five-
membered chelate ring seems to be more associated with the 
type of the counter anion and the presence of extended Au–Cl 
dipolar interactions than with the bulkiness of the alkyl 
substituent at α carbon atom of N-terminal amino acid. 
Crystals are held together by various types of hydrogen bonds 
that are usually formed between cationic and anionic species 
either directly or by means of water molecules. Direct 
hydrogen bond self-association of cationic species is rarely 
encountered. 
 Of a series of the investigated gold(III) complexes, those 
containing X-L-His dipeptides with X is L-Ala (2a and 2b) and L-
Leu (4a and 4b) as N-terminal amino acids turned out to be the 
most active against the investigated microbial strains and to be 
selective in terms of cancer vs. normal cell lines. Moreover, 
these four complexes showed antiangiogenic activity in vivo in 
zebrafish embryos, with 2a and 4b being the most active. 
Although these complexes achieved antiangiogenic effect 
comparable to auranofin and sunitinib malate that are known 
angiogenic inhibitors, at much higher concentration, zebrafish 
embryos upon treatment with gold(III) complexes had no 
cardiovascular side effects. Moreover, overall cytotoxicity and 
embryotoxicity of 2a, 2b, 4a and 4b were significantly lower in 
comparison to auranofin, making them good candidates for 
further development towards antiangiogenic drugs. Finally, all 
investigated gold(III)-dipeptde complexes have significant 
interactions with the active sites of both human and E. coli 
thioredoxin reductases, suggesting that main mechanism of 
their action can be associated with the interaction with this 
enzyme. 
 
Experimental 
 
Materials 
Distilled water was demineralized and purified to a resistance 
of greater than 10 MΩ.cm–1. The compounds K[AuCl4], 
auranofin and D2O were purchased from Sigma-Aldrich 
Chemical Co. The dipeptides glycyl-L-histidine (Gly-L-His), L-
alanyl-L-histidine (L-Ala-L-His), L-valyl-L-histidine (L-Val-L-His) 
and L-leucyl-L-histidine (L-Leu-L-His) were obtained from 
Bachem A.G. All the employed chemicals were of analytical 
reagent grade and used without further purification. 
 
Measurements 
Elemental microanalyses for carbon, hydrogen and nitrogen 
were performed by the Microanalytical Laboratory, Faculty of 
Chemistry, University of Belgrade. All pH measurements were 
made at ambient temperature. The pH meter (S220 
SevenCompact™ pH/Ion, Mettler Toledo) was calibrated with 
buffer solution of pH 4.01. The reported pD values were 
corrected for the deuterium isotopic effect by adding 0.45 
units to the pH meter reading.67 However, in conceptual 
references to acidity and basicity, the common symbol pH was 
used.  1H NMR spectra of gold(III) complexes and L-histidine-
containing dipeptides were recorded at 25 oC in D2O 
containing TSP (sodium 3-(trimethylsilyl)propionate) as the 
internal reference on a Varian Gemini 2000 spectrometer at 
200 MHz. Chemical shifts are reported in parts per million 
(ppm) and scalar couplings are reported in hertz (Hz). 10 mg of 
each compound was dissolved in 0.7 mL of D2O, and this 
solution was transferred into a 5 mm NMR tube. IR spectra 
were recorded as KBr pallets on a Perkin Elmer Spectrum One 
spectrometer over the range 4000 – 450 cm-1. The UV-Vis 
spectra were recorded on a Perkin Elmer Lambda 35 double-
beam spectrophotometer equipped with thermostated 1.00-
cm quartz Suprasil cells after dissolving the corresponding 
gold(III) complex in water over the wavelength range of 200 – 
600 nm. The concentration of the gold(III)-dipeptide 
complexes was 5.10-4 M. 
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Synthesis of gold(III) complexes with L-histidine-containing 
dipeptides 
The gold(III) complexes with L-histidine-containing dipeptides, 
[Au(Gly-L-His-NA,NP,N3)Cl]Cl
.3H2O (1a), [Au(Gly-L-His-
NA,NP,N3)Cl]NO3
.1.25H2O (1b), [Au(L-Ala-L-His-
NA,NP,N3)Cl][AuCl4]
.H2O (2a), [Au(L-Ala-L-His-
NA,NP,N3)Cl]NO3
.2.5H2O (2b), [Au(L-Val-L-His-
NA,NP,N3)Cl]Cl
.2H2O (3), [Au(L-Leu-L-His-NA,NP,N3)Cl]Cl (4a) 
and [Au(L-Leu-L-His-NA,NP,N3)Cl][AuCl4]
.H2O (4b) were 
synthesized by previously described methods.19,20 All 
complexes were pure based on elemental microanalysis and 1H 
NMR spectroscopy.  
0.5 mmol of the corresponding L-histidine-containing 
dipeptide (106.1 mg of Gly-L-His, 113.1 mg of L-Ala-L-His, 127.1 
mg of L-Val-L-His and 134.2 of L-Leu-L-His) was dissolved in 5.0 
mL of water and the pH of solution was adjusted to 1.50 - 2.00 
by adding 1 M HCl (for 1a, 2a, 3 and 4a) or HNO3 (for 1b, 2b, 3 
and 4b). To this solution was added slowly under stirring an 
equimolar amount of K[AuCl4] (188.9 mg) dissolved in 3.0 mL 
of water. The resulting yellow solution was stirred in the dark 
at room temperature for at least seven days. The Au(0) 
particles were filtered off and the filtrate was left standing in 
the dark at room temperature to slowly evaporate to a volume 
of 3.0 mL. The concentrated solution was then stored in 
refrigerator and yellow crystals of gold(III) complexes were 
formed after 3 - 5 days. These crystals were filtered off and 
dried in the dark at ambient temperature. The yield was 71% 
(189.3 mg) for 1a, 68% (179.6 mg) for 1b, 53% (215.8 mg) for 
2a, 65% (183.5 mg) for 2b, 56% (156.0 mg) for 3, 63% (168.6 
mg) for 4a and 52% (222.7 mg) for 4b. 
Anal. calcd. for 1a (C8H17AuCl2N4O6; Mr = 533.12): C, 
18.02%; H, 3.21%; N, 10.51%. Found: C, 17.95%; H, 3.02%; N, 
10.28%. IR (KBr, ν, cm-1): 3530(br), 3131, 3098, 3032, 2916(br), 
1762(s), 1649(s), 1623(vs), 1495(w), 1474(w), 1430(m), 
1397(m), 1336(w), 1313(w), 1285(w), 1256(w), 1205(w), 
1181(w), 1166(m), 1117(m), 1065(w), 1041(w), 967(w), 
946(w), 854(m), 818(w), 775(w), 630(w), 494(w), 480(w). UV-
vis (H2O, λmax, nm): 277 (ε = 1.7
.103 M-1cm-1). 
Anal. calcd. for 1b (C8H13.50AuClN5O7.25; Mr = 528.15): C, 
18.19%; H, 2.58%; N, 13.26%. Found: C, 18.45%; H, 2.42%; N, 
13.08%. IR (KBr, ν, cm-1): 3409(br), 3183, 3120, 3032, 2920(br), 
1731(s), 1654(vs), 1527(w), 1507(w), 1426(m), 1384(vs), 
1342(m), 1278(m), 1174(s), 1124(m), 1086(w), 1033(w), 
980(w), 950(w), 922(w), 853(m), 824(w), 803(m), 699(m), 
630(m), 553(w), 505(m). UV-vis (H2O, λmax, nm): 279 (ε = 
1.1.103 M-1cm-1).   
Anal. calcd. for 2a (C9H15Au2Cl5N4O4; Mr = 814.43): C, 
13.27%; H, 1.86%; N, 6.88%. Found: C, 12.92%; H, 1.80%; N, 
6.80%. IR (KBr, ν, cm-1): 3493(br), 3327(m), 3160, 3121, 
3003(br), 1697(s), 1592(vs), 1506(w), 1451(w), 1435(w), 
1409(m), 1348(w), 1302(w), 1277(m), 1232(m), 1211(m), 
1182(m), 1131(w), 1084(w), 1061(w), 1022(w), 977(w), 942(w), 
928(w), 879(w), 853(w), 809(w), 788(w), 747(w), 689(m), 
620(m), 565(w). UV-vis (H2O, λmax, nm): 289 (ε = 3.5
.103  
M-1cm-1).   
Anal. calcd. for 2b (C9H18AuClN5O8.50; Mr = 564.70): C, 
19.14%; H, 3.21%; N, 12.40%. Found: C, 18.75%; H, 3.18%; N, 
12.23%. IR (KBr, ν, cm-1): 3433(br), 3120, 2917(br), 1737(s), 
1640(s), 1507(w), 1454(w), 1384(vs), 1298(m), 1188(m), 
1114(w), 1084(w), 1014(w), 970(w), 809(w), 630(m), 572(w), 
482(w). UV-vis (H2O, λmax, nm): 289 (ε = 1.1
.103 M-1cm-1).   
Anal. calcd. for 3 (C11H21AuCl2N4O5; Mr = 557.18): C, 
24.50%; H, 3.55%; N, 10.39%. Found: C, 24.29%; H, 3.55%; N, 
10.38%. IR (KBr, ν, cm-1): 3402(br), 3114, 3084, 2965, 2862(br), 
1728(s), 1644(vs), 1508(m), 1470(m), 1431(w), 1390(s), 
1339(m), 1278(m), 1233(m), 1208(s), 1114(w), 1089(m), 
1030(w), 996(w), 838(w), 810(m), 779(m), 767(m), 701(w), 
659(w), 631(m), 587(w), 501(w). UV-vis (H2O, λmax, nm): 282 (ε 
= 1.1.103M-1cm-1).   
Anal. calcd. for 4a (C12H19AuCl2N4O3; Mr = 535.18): C, 
26.93%; H, 3.58%; N, 10.47%. Found: C, 27.03%; H, 3.02%; N, 
10.46%. IR (KBr, ν, cm-1): 3435(br), 3131(m), 2978, 2924(br), 
1722(s), 1646(vs), 1597(m), 1496(m), 1461(m), 1431(m), 
1415(m), 1369(s), 1341(m), 1309(w), 1271(m), 1241(m), 
1198(s), 1144(w), 1123(w), 1087(m), 1025(w), 1012(w), 
971(w), 943(w), 921(w), 856(w), 835(w), 788(m), 675(w), 
663(w), 627(m), 583(w), 531(m). UV-vis (H2O, λmax, nm): 283 (ε 
= 1.6.103 M-1cm-1).   
Anal. calcd. for 4b (C12H21Au2Cl5N4O4; Mr = 856.51): C, 
16.83%; H, 2.47%; N, 6.54%. Found: C, 16.48%; H, 2.36%; N, 
6.47%. IR (KBr, ν, cm-1):  ̴ 3400(br), 3156, 3053, 2962, 2940(br), 
1698(s), 1611(vs), 1506(m), 1457(w), 1403(s), 1344(s), 
1270(m), 1213(m), 1197(m), 1107(w), 1080(m), 1029(w), 
996(w), 963(w), 929(w), 856(w), 823(w), 802(m), 753(w), 
669(w), 648(w), 621(m), 580(w), 516(m). UV-vis (H2O, λmax, 
nm): 281 (ε = 2.5.103 M-1cm-1).   
 
Crystallographic data collection and refinement of the 
structures 
Crystals of the complexes 2a, 3, 4a and 4b suitable for X-ray 
diffraction analysis were obtained by slow evaporation of 
water solution in the presence of hydrochloric and nitric acids. 
The most relevant crystal and refinement data are collected in 
Table S5. Single crystal X-ray diffraction data were collected on 
Xcalibur kappa-geometry diffractometer equipped with Eos 
CCD detector and a graphite monochromated Mo-Kα radiation 
source (λ = 0.71073 Å) using CrysAlisPro software.68 Empirical 
absorption correction using spherical harmonics, implemented 
in SCALE3 ABSPACK scaling algorithm, was also applied.69 The 
structures were solved by direct methods using SHELXS-8670 
and refined by full-matrix least-squares calculations on F2 with 
SHELXL-97.70 Anisotropic displacement parameters were 
refined for all non-hydrogen atoms. All hydrogen atoms were 
refined using a riding model with isotropic displacement 
parameters 20% higher than the isotropic equivalent of their 
carriers. The positions of the hydrogen atoms attached to the 
carbon and nitrogen atoms were calculated at standardized 
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distances (methyl C–H = 0.96, methylene C–H = 0.97, methine 
C–H = 0.98, aromatic C–H = 0.93, aromatic N–H = 0.86 and 
amine N–H = 0.89 Å). The water hydrogen atoms were 
positioned on difference Fourier maps and the O–H distances 
were standardized to 0.82 Å. The hydroxy hydrogen atoms 
were positioned using facilities provided by SHELXL-97; 
HFIX147 at standardized distances (0.82 Å). The absolute 
structure of the crystals was assumed from the known 
absolute configuration of the dipeptides used in the synthesis 
and was confirmed by the Flack parameter.71 MERCURY72 
program was used to prepare drawings. 
 
Biological activity testing 
Evaluation of antimicrobial properties. Gold(III) complexes 
with L-histidine-containing dipeptides, auranofin and K[AuCl4] 
were evaluated against the broad panel of microorganisms 
that included four Gram-positive bacteria (Staphylococcus 
aureus NCTC 6571, Lysteria monocytogenes NCTC 11994, 
Enterococcus faecalis ATCC 29212 and Enterococcus faecium 
ATCC 6057), one Gram-negative (Acinetobacter baumannii 
ATCC 19606) and two strains of Candida (C. albicans ATCC 
10231 and C. parapsilosis ATCC 22019). 
The minimal inhibitory concentration (MIC) values 
corresponding to the lowest concentration that inhibited the 
growth after 24 h at 37 °C, were determined according to the 
standard broth microdilution assays recommended by the 
National Committee for Clinical Laboratory Standards for 
bacteria and yeasts (M07-A8 and M27-A2, respectively) and 
Standards of European Committee on Antimicrobial 
Susceptibility Testing (EDef7.1). The tested compounds were 
dissolved in deionized water. The highest tested concentration 
was 500 μM. The inoculums were 105 colony-forming units  
(cfu mL−1) for bacteria and 104 cfu mL−1 for C. albicans and C. 
parapsilosis. The MIC values were determined in duplicates in 
three independent experiments. 
Cytotoxicity testing. Cytotoxicity in terms of the 
antiproliferative effect was tested by the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
assay.73 The assay was carried out using human lung 
fibroblasts (MRC5), human cervix cancer (HeLa) and lung 
cancer (A549) cell lines after 48 h of cell incubation in the 
medium, containing compounds at concentrations ranging 
from 0.1 to 400 μM. Briefly, cells were maintained in RPMI-
1640 medium supplemented with 100 μg mL-1 streptomycin, 
100 U mL-1 penicillin and 10% (v/v) fetal bovine serum (FBS) 
(all from Sigma, Munich, Germany) as a monolayer (1 × 104 
cells per well) and grown in humidified atmosphere of 95% air 
and 5% CO2 at 37 °C. The extent of MTT reduction was 
measured spectrophotometrically at 540 nm using a Tecan 
Infinite 200 Pro multiplate reader (Tecan Group Ltd., 
Männedorf, Switzerland), and the cell survival was expressed 
as percentage of the control (untreated cells). Cytotoxicity was 
expressed as the concentration of the compound inhibiting 
growth by 50% (IC50). 
Embryotoxicity and antiangiogenic potential evaluation. 
Assessment of toxicity and antiangiogenic activity of gold(III) 
complexes on zebrafish embryos model was carried out 
according to general rules of the OECD Guidelines for the 
Testing of Chemicals.74 All experiments involving zebrafish 
were performed in compliance with the European directive 
86/609/EEC and the ethical guidelines of the Guide for Care 
and Use of Laboratory Animals of the Institute of Molecular 
Genetics and Genetic Engineering, University of Belgrade. 
Adult zebrafish (Danio rerio, wild type) were obtained from 
a commercial supplier (Pet Center, Belgrade, Serbia), housed in 
a light- and temperature-controlled facility with 28 °C and 
standard 14:10-hour light-dark photoperiod, and regularly fed 
twice a day with commercially dry flake food (TetraMinTM 
flakes; Tetra Melle, Germany) supplemented with Artemia 
nauplii. Embryos were obtained by natural spawning and 
raised in the embryo water (0.2 g L-1 of Instant Ocean® Salt in 
distilled water). To examine dose-dependent toxicity of 
gold(III) complexes, auranofin and the corresponding ligands 
embryos at 4 - 6 hours post fertilization (hpf) stage were 
arrayed in 24-well plates, 10 embryos per well, and incubated 
with 1 mL of embryos water per a well containing various 
concentrations of the tested compounds at 28 °C. Embryos 
were exposed to five concentrations of gold(III) complexes 2a, 
2b, 4a and 4b, K[AuCl4], L-Ala-L-His and L-Leu-L-His (12.5, 25, 
50, 75 and 100 μM), and of auranofin (1.25, 2.5, 5, 7.5 and 10 
µM). Embryo water alone was used as negative control. 
Experiments were performed three times using 20 embryos 
per concentration.  
Apical endpoints for toxicity evaluation (Table S6) were 
recorded at 24, 48, 72, 96 and 114 hpf using an inverted 
microscope (CKX41; Olympus, Tokyo, Japan). At 114 hpf 
embryos were inspected for viability, anesthetized by addition 
of 0.1% (w/v) tricaine solution (Sigma-Aldrich, St. Louis, MO), 
photographed and killed by freezing at -20 °C for ≥ 24 h.  
Transgenic zebrafish embryos Tg(fli1:EGFP) expressing 
enhanced green fluorescent protein (EGFP) in endothelial cells 
were kindly obtained from Dr. Ana Cvejic (Wellcome Trust 
Sanger Institute, Cambridge, UK) and raised in our zebrafish 
facility to adult stage under previously described life 
conditions. Transgenic embryos used for the assessment of 
antiangiogenic potential of the tested compounds were 
generated by natural spawning of wild type and Tg(fli1:EGFP) 
adults and reared in embryo water at 28 °C. Embryos staged at 
24 hpf were dechorionated with fine tweezers immediately 
prior to drug treatment, arrayed in 24-well plate with 10 
embryos per well, and incubated with 1 mL of embryo water 
per well containing various concentration of drugs (12.5, 25 
and 35 µM) at 28 °C. After drug treatments, zebrafish embryos 
were anesthetized with 0.003% tricaine (Sigma-Aldrich) and 
subsequently photographed. The intersegmental blood vessels 
(ISVs) and subintestinal vessel plexus (SIVs) development were 
inspected and imaged in embryos at 48 and 72 hpf, 
respectively under a fluorescence microscope (Olympus BX51, 
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Applied Imaging Corp., San Jose, CA, USA). Auranofin (Sigma-
Aldrich) and sunitinib malate (Suten, Pfizer, New York) were 
used as a positive controls with known antiangiogenic activity, 
including in zebrafish embryo model.30,75  
 
Molecular docking study 
The geometry optimization of studied complexes have been 
carried out with the application of semi-empirical quantum 
chemistry method (PM6),76,77 because of its excellent 
compromise between computational time and description of 
electronic correlation.78 The calculations were performed with 
the Gaussian 09 molecular package.79 The crystal structures of 
human and E. coli thioredoxin reductases were obtained from 
the Brookhaven Protein Data Bank http://www.rcsb.org/pdb 
(PDB entries: 2ZZ0 and 1TDE, respectively). Molegro Virtual 
Docker (MVD v. 2013.6.0.1.) software was employed for 
docking complexes into the rigid enzyme model, for 
identification of hydrogen bonds and hydrophobic interactions 
between residues at the active site and for calculation of 
relevant binding energies.80 The binding site was computed 
with a grid resolution of 0.3 Å. The MolDock SE was used as a 
search algorithm, with the number of runs set to 100. Docking 
procedure’s parameters were: population size 50, maximum 
number of iterations 1500, energy threshold 100.00 and 
maximum number of steps 300. The maximum number of 
generated poses was 10. The estimation of interactions 
between gold(III) complexes and auranofin, and receptor was 
described by the MVD-related scoring functions: HBond, 
NoHBond, steric, VdW, energy, MolDock score, Rerank score, 
LE1 and LE3. The complex was docked into this grid using the 
MolDock Optimizer algorithm and its interactions were 
monitored using detailed energy estimates. A maximum 
population of 100 and maximum iterations of 10 000 were 
used for each run and the 5 best poses were retained. For 
creating two dimensional representations of interactions 
between complex and enzyme LigPlot+ software was used.81 
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Mononuclear gold(III) complexes with L-histidine-containing dipeptides: 
tuning the structural and biological properties by variation of the N-terminal 
amino acid and counter anion 
 
 
 
Cytotoxicity and embryotoxicity of gold(III) complexes with L-histidine-containing dipeptides, 
in which N-terminal amino acid is L-alanine and L-leucine, were significantly lower in 
comparison to auranofin, making them good candidates for further development towards 
antiangiogenic drugs. 
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